METHOD OF PREPARING /E/-5-/2-BROMOVINYL/URIDINE AND DERIVATIVES THEREOF

The invention relates to (E)-5-(2-bromovinyl)-uridine and its derivatives of general formula VI, VI wherein R1 stands for a hydrogen atom, C1-8 alkanoyl group, benzoyl group or a benzoyl group substituted in para position either with a C1-4 alkyl group or a halogen atom, and a process for preparing...

Full description

Saved in:
Bibliographic Details
Main Authors HORVATH ISTVAN DR.,HU, IVAN,PAL,HU, VTRITZSCHE,ILDIKO,HU, KOCZKA ISTVAN DR.,HU, SAGI JANOS DR.,HU, PEREDY MARIA DR.,HU, SZEMZOE ATTILA DR.,HU, REDHATI,CSSILA,HU, SZABOLCS ANNA DR.,HU, OETVOES LASZLO DR.,HU
Format Patent
LanguageEnglish
Published 14.05.1984
Edition3
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to (E)-5-(2-bromovinyl)-uridine and its derivatives of general formula VI, VI wherein R1 stands for a hydrogen atom, C1-8 alkanoyl group, benzoyl group or a benzoyl group substituted in para position either with a C1-4 alkyl group or a halogen atom, and a process for preparing them by brominating 2',3',5'-tri-O-acyl-5-ethyl-uridine of general formula IV, IV wherein R is identical with R1, except where R1 stands for a hydrogen atom, dehydrohalogenating the resulting dibromo compound of general formula V V and optionally deacylating it. The resulting compounds of general formula VI are exhibiting significant potency against Herpes simplex virus species and are of remarkably low acute toxicity.
Bibliography:Application Number: CS19820006394